clarithromycin has been researched along with carbocysteine in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (50.00) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
| Ishizaka, T; Mukai, J; Okada, S; Takemoto, E; Tokuyama, E; Tsuji, E; Uchida, T | 1 |
| Akamine, Y; Asada, Y; Hori, S; Isono, K; Kanou, M; Kinosita, M; Kunoki, Y; Matsuo, R; Miki, A; Ohtani, H; Satoh, H; Sawada, Y; Sawai, H; Sudou, T; Tanaka, S; Tanaka, Y; Taura, T | 1 |
| Harada, T; Haruna, S; Hirakawa, K; Ichimura, K; Kase, Y; Kawauchi, H; Kurono, Y; Majima, Y; Moriyama, H; Naito, K; Suzaki, H; Takeuchi, K | 1 |
| Iino, Y; Kakizaki, K; Kakuta, H; Kato, T; Miyazawa, T; Yoshida, N | 1 |
| Baba, N; Higashi, Y; Kanekura, T; Sakaguchi, I; Yoshimine, H | 1 |
2 trial(s) available for clarithromycin and carbocysteine
| Article | Year |
|---|---|
Efficacy of combined treatment with S-carboxymethylcysteine (carbocisteine) and clarithromycin in chronic rhinosinusitis patients without nasal polyp or with small nasal polyp.
Topics: Adult; Aged; Anti-Bacterial Agents; Carbocysteine; Chronic Disease; Clarithromycin; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Nasal Polyps; Prospective Studies; Quality of Life; Rhinitis; Sinusitis; Tomography, X-Ray Computed | 2012 |
Clinical effects of clarithromycin on persistent inflammation following Haemophilus influenzae-positive acute otitis media.
Topics: Anti-Bacterial Agents; Anti-Infective Agents, Local; Carbocysteine; Child; Child, Preschool; Clarithromycin; Drug Therapy, Combination; Female; Haemophilus Infections; Haemophilus influenzae; Humans; Infant; Male; Otitis Media; Treatment Failure | 2015 |
4 other study(ies) available for clarithromycin and carbocysteine
| Article | Year |
|---|---|
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
The suppression of enhanced bitterness intensity of macrolide dry syrup mixed with an acidic powder.
Topics: Anti-Bacterial Agents; Carbocysteine; Clarithromycin; Flavoring Agents; Humans; Hydrogen-Ion Concentration; Macrolides; Pharmaceutical Solutions; Powders; Solubility; Solutions; Suspensions; Taste Threshold; Time Factors | 2007 |
[Bitterness of the mixture of clarithromycin dry syrup and carbocisteine preparation--difference between brand name and generic drugs].
Topics: Anti-Bacterial Agents; Carbocysteine; Chemistry, Pharmaceutical; Clarithromycin; Dosage Forms; Drug Combinations; Drug Compounding; Drugs, Generic; Humans; Hydrogen-Ion Concentration; Male; Taste; Taste Threshold | 2008 |
Late-onset interstitial nephritis in a patient with drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms.
Topics: Acetaminophen; Biopsy; Carbocysteine; Clarithromycin; Creatinine; Drug Hypersensitivity Syndrome; Drug Therapy, Combination; Drugs, Chinese Herbal; Fatigue; Humans; Kidney; Male; Middle Aged; Muramidase; Nephritis, Interstitial; Prednisolone; Skin; Time Factors | 2020 |